The Non-Insured Health Benefits (NIHB) program establishes exemplary coverage for Dexcom’s real-time continuous glucose monitoring system – bringing game-changing technology to more First Nations and ...
Dexcom G6 is the first Continuous Glucose Monitoring (CGM) System to be listed by the NIHB Drug Benefit program. BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), a leader in ...
The world’s most connected continuous glucose monitoring system, † Dexcom G6, is now the first and only CGM to connect with the Omnipod 5 Automated Insulin Delivery (AID) System in Germany. MAINZ, ...
Portfolio includes Dexcom G7, Dexcom ONE and Dexcom G6 and offers the most powerful, easy to use, connected and covered CGM options for people living with diabetes around the world. The portfolio is ...
Advances in CGM technology has been life-altering to those living with diabetes. According to the Diabetes Research Institute Foundation, "34.2 million people, or 10.5% of the US population, have ...
Stelo is now part of Dexcom’s overall portfolio of glucose biosensors, with a user base of more than 2.5 million people globally. The Dexcom portfolio in the U.S. consists of the Dexcom G6 and Dexcom ...
Stream NBC 5 for free, 24/7, wherever you are. Stelo is an over-the-counter CGM that pokes through the skin to measure real-time blood sugar levels. The sensor launched in August and can be used by ...